India’s first indigenously developed glycoprotein E (gE) deleted DIVA marker vaccine against infectious bovine rhinotracheitis (IBR) was launched recently.
The vaccine named Raksha-IBR will address infertility, abortions and reduced milk productivity linked to the disease.
IBR is endemic in India and caused by Bovine Herpes Virus (BHV-1).
The disease is transmitted through the aerosol route and affects the reproductive systems.
It is also transmitted by semen from bulls to milch animals.
Infertility, abortions and lower milk productivity are some of the major impacts of the disease.
There is no vaccine available in India and there is no specific treatment against this disease thus far.